Stay updated with breaking news from System Atrophy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Alterity Therapeutics Announces Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial in the United Kingdom - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying...
/PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying...
Scientists in Lausanne, Switzerland fitted Nirina with an 'electronic stimulator', implanted directly on her spinal cord, to reactivate specific neurons that regulate blood pressure.
Here are the family announcements carried in the Stroud News and Journal this week.